Indorama Ventures posts 18% growth in sales volumes in 2020
IVL is undergoing various transformative initiatives, on our journey towards establishing institutional excellence and efficiency.
IVL is undergoing various transformative initiatives, on our journey towards establishing institutional excellence and efficiency.
These awards are a recognition of the company's commitment to deliver value and support the continued growth across their markets.
Initially 10% of the gas feed will be replaced by hydrogen.
Janus will chair the upcoming 2021 AGM, scheduled to take place on 24 June 2021.
The company accelerated its digital transformation and successfully expanded its presence in several parts of the world in 2020.
BASF aims to increase its sales to between €61 billion and €64 billion in 2021.
The tenure is for 7 years including 2 years moratorium period.
The project is expected to be commissioned by September 2024.
UOP will provide a range of technology licenses, engineering design, key equipment and state-of-the-art catalysts and adsorbents, operator training, and technical services for start-up and continuing operations
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
The divestment of PMMA is expected to close in mid-year.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
IWAI inks MoU with MOL (Asia Oceania)
Bpifrance Participations will increase its shareholding in the Target to a stake of 14.07-20%.
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
Company intends to use results from the Baytown trial to scale-up advanced recycling capabilities at other global facilities, targeting a circular solution for converting difficult-to-recycle plastic waste into feedstock for virgin-quality plastic
The expansion project, budgeted at $61 million, will be rolled out in 2021 and should be concluded in the fourth quarter of 2022
Net sales for the full year 2020 were down 10% organically.
Subscribe to our newsletter & stay updated.